Bicycle Therapeutics Plc (BCYC)
7.31
-0.02
(-0.27%)
USD |
NASDAQ |
Dec 16, 16:00
7.30
-0.01
(-0.14%)
After-Hours: 20:00
Bicycle Therapeutics Research and Development Expense (TTM): 279.03M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Adaptimmune Therapeutics Plc | 135.11M |
| Biodexa Pharmaceuticals Plc | 6.352M |
| NuCana Plc | 15.52M |
| Autolus Therapeutics Plc | 112.76M |
| Mereo BioPharma Group Plc | 22.37M |